WCMN
CELG

Westchester Capital Management (Nebraska)’s Celgene Corp CELG Stock Holding History

Westchester Capital Management (Nebraska)’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-200
Closed -$12K – 70
2013
Q2 		$12K Buy
+200
New +$12K 0.01% 50

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westchester Capital Management (Nebraska)'s CELG Position: Q3 2013 in Review

Westchester Capital Management (Nebraska) sold out of Celgene Corp (CELG) in Q3 2013, closing a stake of 200 shares — an estimated $12K sold.

Westchester Capital Management (Nebraska) first reported a position in CELG in Q2 2013 and held it in 1 quarter. The position peaked at $12K in Q2 2013. 909 funds tracked by Wall St. Rank hold CELG as of Q3 2013.

  • Westchester Capital Management (Nebraska) reported no remaining Celgene Corp position as of Q3 2013 after selling out during the quarter.
  • Westchester Capital Management (Nebraska) sold 200 Celgene Corp shares in Q3 2013, an estimated $12K.
  • Westchester Capital Management (Nebraska) first reported a position in Celgene Corp in Q2 2013 and held it in 1 quarter.
  • Westchester Capital Management (Nebraska)'s Celgene Corp position peaked at $12K in Q2 2013.
  • 909 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2013.

Based on Westchester Capital Management (Nebraska)'s 13F filing for Q3 2013, filed 28 Oct 2013.